Related Experiment Video

Updated: Jul 15, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

The antitumor effects of interferon: a personal history

Ion Gresser1

  • 1Unité Inserm 255, Centre de Recherches Biomédicales des Cordeliers, UPMC, 15 rue de l'Ecole de Médecine 75270 Paris, France. ion.gresser@club-internet.fr

Biochimie
|April 25, 2007
PubMed

Insights

Interferon alpha/beta inhibits tumor growth in mice by activating host immune mechanisms. Endogenous interferon alpha/beta is crucial for the mouse

Area of Science:

  • Immunology
  • Virology
  • Oncology

Background:

  • Early research indicated that mouse interferon preparations could prevent viral-induced and spontaneous leukemias in mice.
  • Interferon alpha/beta demonstrated inhibitory effects on the growth of various transplantable tumors across different mouse strains.

Observation:

  • Interferon alpha/beta's ability to inhibit tumors resistant to its effects suggested the involvement of interferon-induced host mechanisms.
  • The interaction between interferon alpha/beta and the immune system was explored as a key component of its antitumor activity.

Findings:

  • Interferon alpha/beta plays a critical role in the host's defense against tumor development.
  • Neutralizing antibodies against interferon alpha/beta confirmed its essential function in preventing syngeneic, allogeneic, and xenogeneic tumor growth.

Implications:

  • These findings highlight interferon alpha/beta as a significant factor in anti-tumor immunity.
  • Understanding these host mechanisms could lead to novel therapeutic strategies for cancer treatment.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.